4//SEC Filing
ARENA PHARMACEUTICALS INC 4
Accession 0001371859-16-000002
CIK 0001080709operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 8:55 PM ET
Size
7.5 KB
Accession
0001371859-16-000002
Insider Transaction Report
Form 4
White Christine Anna
Director
Transactions
- Sale
Common Stock
2016-06-13$1.99/sh−18,728$37,299→ 85,529 total - Award
Stock Option (right to buy)
2016-06-13+125,000→ 125,000 totalExercise: $2.00Exp: 2023-06-13→ Common Stock (125,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $1.965 to $2.04 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 13, 2016, and are exercisable once vested.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001080709
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 8:55 PM ET
- Size
- 7.5 KB